They slow gastric emptying, alter gut motility, and shift the bacterial landscape of your intestines
For instance, Hirsch said he sometimes prescribes a 2 mg pen of Ozempic to be used in 0.5 mg doses
GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases [Internet]
A meta-analysis was conducted to investigate the link between GLP-1-1 RA treatment and gallbladder and biliary diseases
Smaller portions, higher expectations Consumers are eating less, which means: Every bite needs to deliver flavour Nutritional density becomes more important There is less tolerance for bland or unbalanced products Shift in taste preferences Some consumers report: Reduced desire for very sweet or fatty foods Increased sensitivity to bitterness or off-notes Changes in overall flavour perception This creates challenges for food manufacturers where foods contain: High fat, sugar or salt (HFSS) products, where consumer preferences may shift Functional or fortified products, where active ingredients can introduce off-notes High-protein formulations, which are increasingly important but can present challenges in taste, mouthfeel and flavour balance Increased focus on nutrition With reduced food intake, products need to work harder nutritionally
Wet skin can cause stinging during injection